GlassScriptPhysician profile
Evan Schreyer
NPI 1861841157
$1,773.30
in general payments reported to CMS, 2019-2025
17 companies · $716 in 2025
The $716 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $197 · 2020: $271 · 2021: $136 · 2022: $89.99 · 2023: $151 · 2024: $213 · 2025: $716.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,080.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,079.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $297.67 | 2019-2023 | Fasenra |
| Medtronic, INC. | $282.93 | 2024-2025 | Corevalve Evolut R |
| E.R. Squibb & Sons, L.L.C. | $247.88 | 2023-2025 | Camzyos, Eliquis |
| Astellas Pharma US INC | $188.99 | 2020-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $152.72 | 2019-2021 | |
| Boston Scientific Corporation | $115.77 | 2025 | Watchman Flx |
| Philips North America LLC | $98.00 | 2025 | US Eq Undivided |
| Abiomed | $69.44 | 2024 | Impella |
| Janssen Pharmaceuticals, INC | $67.32 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $51.40 | 2020-2025 | Jardiance |
| Abbott Laboratories | $43.10 | 2025 | Aveir |
| Lantheus Medical Imaging, INC. | $36.32 | 2020-2025 | |
| Alexion Pharmaceuticals, INC. | $26.87 | 2023 | |
| Novartis Pharmaceuticals Corporation | $26.67 | 2023 | |
| Angiodynamics, INC. | $26.29 | 2024 | Angiovac |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $23.22 | 2020 | |
| Pfizer INC. | $18.71 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evan Schreyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.